Dmitry Balyasny’s Meridian Bioscience Inc VIVO Stock Holding History

Dmitry Balyasny’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7,357	Closed	-$244K	–	3415
2022 Q4	$244K	Buy	+7,357	New	+$237K	﹤0.01%	2062
2021 Q4	–	Sell	-140,148	Closed	-$2.7M	–	2714
2021 Q3	$2.7M	Buy	140,148 +124,715	+808%	+$2.49M	0.01%	1030
2021 Q2	$342K	Buy	+15,433	New	+$327K	﹤0.01%	1628
2020 Q3	–	Sell	-253,273	Closed	-$5.9M	–	1681
2020 Q2	$5.9M	Buy	253,273 +52,686	+26%	+$764K	0.05%	476
2020 Q1	$1.69M	Buy	+200,587	New	+$1.69M	0.02%	648
2016 Q4	–	Sell	-20,373	Closed	-$393K	–	1524
2016 Q3	$393K	Sell	20,373 -6,000	-23%	-$117K	﹤0.01%	778
2016 Q2	$514K	Sell	26,373 -4,985	-16%	-$97.8K	﹤0.01%	820
2016 Q1	$646K	Buy	31,358 +15,700	+100%	+$309K	﹤0.01%	836
2015 Q4	$321K	Buy	+15,658	New	+$300K	﹤0.01%	952

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Dmitry Balyasny's VIVO Position: Q1 2023 in Review

Dmitry Balyasny sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 7,357 shares — an estimated $244K sold.

Dmitry Balyasny first reported a position in VIVO in Q4 2015 and held it in 9 quarters. The position peaked at $5.9M in Q2 2020. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Dmitry Balyasny reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Dmitry Balyasny sold 7,357 Meridian Bioscience Inc shares in Q1 2023, an estimated $244K.
Dmitry Balyasny first reported a position in Meridian Bioscience Inc in Q4 2015 and held it in 9 quarters.
Dmitry Balyasny's Meridian Bioscience Inc position peaked at $5.9M in Q2 2020.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Balyasny Asset Management's 13F filing for Q1 2023, filed 15 May 2023.